They explained the licensing delay in the last 4C:
"Exclusivity and Licensing Agreements: The Company has been engaged in exclusivity and licensing discussions with multiple players across two specific technologies, Alexiflam SYNTM and AlexiflamTM NF. Given the value of these license opportunities, Alexium has conducted a process of engaging with multibillion-dollar global chemical companies within specific markets. The Company had been expecting to close a license deal in the December quarter but with the need to balance the returns from marketing these products itself versus significant passive license income and the number of engaged companies, the Company is taking additional time to achieve the best value exclusivity agreements for both the NF and SYN products with a global chemical manufacturer and supplier."
- Forums
- ASX - By Stock
- AJX
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-34
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJX (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.49M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $0 | 2 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1321409 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 57000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1321409 | 0.008 |
6 | 3850194 | 0.007 |
4 | 581167 | 0.006 |
1 | 300000 | 0.005 |
1 | 500000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 57000 | 1 |
0.010 | 150000 | 2 |
0.011 | 1000000 | 2 |
0.013 | 669958 | 2 |
0.014 | 134311 | 1 |
Last trade - 14.03pm 02/09/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |